Canada · Delayed Price · Currency is CAD BioNxt Solutions Statistics
Total Valuation
CSE:BNXT has a market cap or net worth of CAD 58.32 million. The enterprise value is 64.22 million.
| Market Cap | 58.32M |
| Enterprise Value | 64.22M |
Important Dates
The next estimated earnings date is Friday, May 1, 2026.
| Earnings Date | May 1, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:BNXT has 129.61 million shares outstanding. The number of shares has increased by 6.04% in one year.
| Current Share Class | 129.61M |
| Shares Outstanding | 129.61M |
| Shares Change (YoY) | +6.04% |
| Shares Change (QoQ) | +3.59% |
| Owned by Insiders (%) | 5.61% |
| Owned by Institutions (%) | n/a |
| Float | 122.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -6.23 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.14 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.05
| Current Ratio | 0.05 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.12 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -638.57% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 110.18% |
| Weighted Average Cost of Capital (WACC) | 12.65% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 20 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -197,469 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.94% in the last 52 weeks. The beta is 1.41, so CSE:BNXT's price volatility has been higher than the market average.
| Beta (5Y) | 1.41 |
| 52-Week Price Change | +14.94% |
| 50-Day Moving Average | 0.55 |
| 200-Day Moving Average | 0.69 |
| Relative Strength Index (RSI) | 49.43 |
| Average Volume (20 Days) | 35,414 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.93M |
| Pretax Income | -7.22M |
| Net Income | -7.03M |
| EBITDA | -5.92M |
| EBIT | -5.93M |
| Earnings Per Share (EPS) | -0.06 |
Balance Sheet
The company has 55,264 in cash and 5.95 million in debt, with a net cash position of -5.89 million or -0.05 per share.
| Cash & Cash Equivalents | 55,264 |
| Total Debt | 5.95M |
| Net Cash | -5.89M |
| Net Cash Per Share | -0.05 |
| Equity (Book Value) | -9.37M |
| Book Value Per Share | -0.08 |
| Working Capital | -5.65M |
Cash Flow
| Operating Cash Flow | -5.20M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 10,903 |
| Net Borrowing | 2.93M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:BNXT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.04% |
| Shareholder Yield | -6.04% |
| Earnings Yield | -12.05% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |